Sources | Names Used |
---|---|
CTRPv2 | BRD-K63431240 |
PharmacoGx | BRD-K63431240 |
Database | Identifier |
---|---|
Smiles: | C[C@@H](CO)N1C[C@H](C)[C@@H](CN(C)C(=O)Nc2ccc3OCOc3c2)Oc4cc(C#Cc5ccncc5)ccc4S1(=O)=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KANK3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | CD81 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | PDCD4 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
mRNA | NXNL2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
mRNA | C14orf1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | PRX | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | CT45A3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
mRNA | AGER | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | NFATC2IP | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | SH2D4B | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |